BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2431582)

  • 1. Tissue distribution of aromatic retinoid (etretinate) in three autopsy cases: drug accumulation in adrenals and fat.
    Vahlquist A; Rollman O; Pihl-Lundin I
    Acta Derm Venereol; 1986; 66(5):431-4. PubMed ID: 2431582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
    Kingston TP; Matt LH; Lowe NJ
    Arch Dermatol; 1987 Jan; 123(1):55-8. PubMed ID: 2948451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of tissue distribution and elimination of retinoid drugs in the rat. II. Etretinate.
    Eisenhardt EU; Bickel MH
    Drug Metab Dispos; 1994; 22(1):31-5. PubMed ID: 8149886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
    Larsen FG; Jakobsen P; Larsen CG; Kragballe K; Nielsen-Kudsk F
    Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
    Bjerke JR; Geiger JM
    Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
    Kochhar DM; Penner JD; Minutella LM
    Drug Metab Dispos; 1989; 17(6):618-24. PubMed ID: 2575497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate.
    Rollman O; Vahlquist A
    Br J Dermatol; 1983 Oct; 109(4):439-47. PubMed ID: 6226308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An appraisal of acitretin therapy in children with inherited disorders of keratinization.
    Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI
    Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etretinate may work where acitretin fails.
    Bleiker TO; Bourke JF; Graham-Brown RA; Hutchinson PE
    Br J Dermatol; 1997 Mar; 136(3):368-70. PubMed ID: 9115918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
    Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin, adipose tissue and plasma levels of acitretin with rare occurrence of esterified acitretin during long-term treatment.
    Meyer E; de Bersaques J; Lambert WE; de Leenheer AP; Kint AH
    Acta Derm Venereol; 1993 Apr; 73(2):113-5. PubMed ID: 8103254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.
    Lauharanta J; Paravicini U
    Arch Dermatol Res; 1982; 272(1-2):147-9. PubMed ID: 6219628
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions.
    Park HD; Kim HK; Kim JW; Kim DW; Lee JH; Huh W; Youn JI; Kim HG; Kim YG; Kim MH; Lee SY
    Transfusion; 2008 Nov; 48(11):2395-400. PubMed ID: 18657077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H; Sönnichsen N
    Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 16. Etretinate pharmacokinetics in chronic renal failure. A preliminary study in psoriasis patients.
    Vahlquist A
    Dermatologica; 1987; 175(5):224-8. PubMed ID: 2960573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason).
    Jagell S; Lidén S
    Acta Derm Venereol; 1983; 63(1):89-91. PubMed ID: 6191505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoids in psoriasis and disorders of keratinization.
    Fritsch PO
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 2):S8-14. PubMed ID: 1460124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acitretin in the symptomatic therapy for severe recessive x-linked ichthyosis.
    Bruckner-Tuderman L; Sigg C; Geiger JM; Gilardi S
    Arch Dermatol; 1988 Apr; 124(4):529-32. PubMed ID: 2965549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid changes during acitretin (etretin) treatment of psoriasis and palmo-plantar pustulosis.
    Vahlquist C; Selinus I; Vessby B
    Acta Derm Venereol; 1988; 68(4):300-5. PubMed ID: 2459874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.